Engineers Gate Manager LP

Position in COGT — Cogent Biosciences, Inc.

CIK 1620220 NEW YORK, NY

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$474,732

-$1,141,463 QoQ

Shares Held

12,267

-70.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#210

of 321 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. COGT ranks #97 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$474,732	12,267	-70.8%	Shares	Sole	2026-08-14
2026-03-31	$1,616,195	41,990	+59.3%	Shares	Sole	2026-05-15
2025-12-31	$936,555	26,367	-72.7%	Shares	Sole	2026-02-17
2025-09-30	$1,385,538	96,486	+6.9%	Shares	Sole	2025-11-14
2025-06-30	$648,152	90,272	+248.3%	Shares	Sole	2025-08-14
2025-03-31	$155,236	25,916	-44.8%	Shares	Sole	2025-05-15
2024-12-31	$366,085	46,934	+309.5%	Shares	Sole	2025-02-14
2023-12-31	$67,384	11,460	-57.6%	Shares	Sole	2024-02-14
2023-06-30	$319,904	27,019	+14.9%	Shares	Sole	2023-08-14
2023-03-31	$253,759	23,518	-3.2%	Shares	Sole	2023-05-15
2022-12-31	$280,942	24,303	+31.2%	Shares	Sole	2023-02-14
2021-03-31	$162,640	18,524	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.